JP2019506175A5 - - Google Patents

Download PDF

Info

Publication number
JP2019506175A5
JP2019506175A5 JP2018544819A JP2018544819A JP2019506175A5 JP 2019506175 A5 JP2019506175 A5 JP 2019506175A5 JP 2018544819 A JP2018544819 A JP 2018544819A JP 2018544819 A JP2018544819 A JP 2018544819A JP 2019506175 A5 JP2019506175 A5 JP 2019506175A5
Authority
JP
Japan
Prior art keywords
seq
signal peptide
nucleic acid
ige signal
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018544819A
Other languages
English (en)
Japanese (ja)
Other versions
JP7012365B2 (ja
JP2019506175A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/019407 external-priority patent/WO2017147458A1/en
Publication of JP2019506175A publication Critical patent/JP2019506175A/ja
Publication of JP2019506175A5 publication Critical patent/JP2019506175A5/ja
Priority to JP2021189383A priority Critical patent/JP7555325B2/ja
Application granted granted Critical
Publication of JP7012365B2 publication Critical patent/JP7012365B2/ja
Priority to JP2024073806A priority patent/JP2024096281A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018544819A 2016-02-25 2017-02-24 ジカウイルスに対する新規のワクチン Active JP7012365B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2021189383A JP7555325B2 (ja) 2016-02-25 2021-11-22 ジカウイルスに対する新規のワクチン
JP2024073806A JP2024096281A (ja) 2016-02-25 2024-04-30 ジカウイルスに対する新規のワクチン

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US201662300030P 2016-02-25 2016-02-25
US62/300,030 2016-02-25
US201662305183P 2016-03-08 2016-03-08
US62/305,183 2016-03-08
US201662396742P 2016-09-19 2016-09-19
US62/396,742 2016-09-19
US201662417100P 2016-11-03 2016-11-03
US62/417,100 2016-11-03
US201762462249P 2017-02-22 2017-02-22
US62/462,249 2017-02-22
PCT/US2017/019407 WO2017147458A1 (en) 2016-02-25 2017-02-24 Novel vaccines against zika virus

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021189383A Division JP7555325B2 (ja) 2016-02-25 2021-11-22 ジカウイルスに対する新規のワクチン

Publications (3)

Publication Number Publication Date
JP2019506175A JP2019506175A (ja) 2019-03-07
JP2019506175A5 true JP2019506175A5 (https=) 2020-04-02
JP7012365B2 JP7012365B2 (ja) 2022-03-04

Family

ID=59685658

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018544819A Active JP7012365B2 (ja) 2016-02-25 2017-02-24 ジカウイルスに対する新規のワクチン
JP2021189383A Active JP7555325B2 (ja) 2016-02-25 2021-11-22 ジカウイルスに対する新規のワクチン
JP2024073806A Pending JP2024096281A (ja) 2016-02-25 2024-04-30 ジカウイルスに対する新規のワクチン

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2021189383A Active JP7555325B2 (ja) 2016-02-25 2021-11-22 ジカウイルスに対する新規のワクチン
JP2024073806A Pending JP2024096281A (ja) 2016-02-25 2024-04-30 ジカウイルスに対する新規のワクチン

Country Status (10)

Country Link
US (2) US11648303B2 (https=)
EP (1) EP3419660A4 (https=)
JP (3) JP7012365B2 (https=)
KR (1) KR20190003471A (https=)
CN (2) CN115927399A (https=)
AU (3) AU2017222644B2 (https=)
BR (1) BR112018017307A2 (https=)
CA (1) CA3015792A1 (https=)
MX (2) MX2018010291A (https=)
WO (1) WO2017147458A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA42502A (fr) 2015-07-21 2018-05-30 Modernatx Inc Vaccins contre une maladie infectieuse
US11364292B2 (en) 2015-07-21 2022-06-21 Modernatx, Inc. CHIKV RNA vaccines
WO2017070624A1 (en) 2015-10-22 2017-04-27 Modernatx, Inc. Tropical disease vaccines
AU2017222644B2 (en) 2016-02-25 2021-07-29 The Trustees Of The University Of Pennsylvania Novel vaccines against Zika virus
CA3040123A1 (en) * 2016-10-11 2018-04-19 University Of Miami Vectors and vaccine cells for immunity against zika virus
US11806393B2 (en) * 2017-02-10 2023-11-07 La Jolla Institute For Allergy And Immunology Flavivirus peptide sequences, epitopes, and methods and uses thereof
MA47515A (fr) 2017-02-16 2019-12-25 Modernatx Inc Compositions immunogènes très puissantes
WO2019055807A1 (en) 2017-09-14 2019-03-21 Modernatx, Inc. RNA VACCINES AGAINST ZIKA VIRUS
KR20200117981A (ko) 2017-11-03 2020-10-14 다케다 백신즈 인코포레이티드 지카 백신 및 면역원성 조성물, 그리고 이를 이용하는 방법들
MX2020005554A (es) 2017-11-30 2020-10-12 Takeda Vaccines Inc Vacunas y composiciones inmunogenas para zika y metodos para usarlas.
US11491217B2 (en) 2017-12-06 2022-11-08 Emory University Chimeric viruses encoding mutant zika virus envelope glycoproteins
EP3826672A4 (en) 2018-07-23 2022-04-20 The University of Adelaide VACCINE AGAINST THE ZIKA VIRUS
WO2020092564A1 (en) * 2018-10-31 2020-05-07 Icahn School Of Medicine At Mount Sinai Human antibodies targeting zika virus ns1, ns1 polypeptides and uses thereof
US12070495B2 (en) 2019-03-15 2024-08-27 Modernatx, Inc. HIV RNA vaccines
US20250269010A1 (en) * 2021-02-05 2025-08-28 St Pharm Co., Ltd. Novel nucleic acid molecule

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU774045B2 (en) * 1998-09-02 2004-06-17 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Dengue viruses that are replication defective in mosquitos for use as vaccines
EP2026839A4 (en) * 2005-12-14 2009-04-01 Univ Oklahoma RNA VIRUS VACCINE AND METHODS
KR101686942B1 (ko) 2008-01-11 2016-12-28 이노비오 파마수티컬즈, 인크. 뎅기 바이러스 다중 서브타입에 대항하는 신규한 백신
EP2358733B1 (en) * 2008-11-17 2015-07-08 Inovio Pharmaceuticals, Inc. Antigens that elicit immune response against flavivirus and methods of using same
WO2011032179A1 (en) * 2009-09-14 2011-03-17 The Trustees Of The University Of Pennsylvania Vaccines and immunotherapeutics comprising il-15 receptor alpha and/or nucleic acid molecules encoding the same, and methods for using the same
KR102138780B1 (ko) 2009-11-02 2020-07-29 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 구제역 바이러스(fmdv) 공통 단백질, 이를 위한 코딩 서열 및 이로부터 만들어진 백신
US8691961B1 (en) 2009-11-09 2014-04-08 Integral Molecular, Inc. Flavivirus reporter virus and methods of making and using the same
WO2011115583A1 (en) 2010-03-19 2011-09-22 National University Of Singapore A novel platform for retrovirus-like particle (vlp)-display of vaccine antigens
EP2550292B1 (en) * 2010-03-24 2017-11-22 Research Development Foundation Flavivirus host range mutations and uses thereof
CA2819552C (en) * 2010-12-09 2023-09-26 Institut Pasteur Mgmt-based method for obtaining high yield of recombinant protein expression
EA033467B1 (ru) 2011-01-31 2019-10-31 Univ Pennsylvania Молекула нуклеиновой кислоты для индукции иммунного ответа против герпесвируса и ее применение
BR112014013745B1 (pt) 2011-12-09 2022-06-14 Institut Pasteur Método de teste in vitro, kit de detecção e seu uso, método in vitro de diagnóstico, método de fabricação de kit, e teste de imunosseleção multiplex
WO2014144786A1 (en) 2013-03-15 2014-09-18 The Trustees Of The University Of Pennsylvania Novel vaccines against multiple subtypes of dengue virus
EP3322441A4 (en) 2015-07-16 2018-12-19 Bharat Biotech International Limited Vaccine compositions
MA42502A (fr) * 2015-07-21 2018-05-30 Modernatx Inc Vaccins contre une maladie infectieuse
WO2017070624A1 (en) * 2015-10-22 2017-04-27 Modernatx, Inc. Tropical disease vaccines
SG10201913630YA (en) * 2016-02-17 2020-03-30 Curevac Ag Zika virus vaccine
AU2017222644B2 (en) * 2016-02-25 2021-07-29 The Trustees Of The University Of Pennsylvania Novel vaccines against Zika virus
MX2019000725A (es) * 2016-07-18 2019-07-04 Variation Biotechnologies Inc Composiciones de vacuna para tratamiento de virus zika.
BR112019005378A2 (pt) * 2016-09-19 2019-08-27 The Trustees Of The University Of Pennsylvania molécula de ácido nucleico, composição, e, métodos para prevenir ou tratar uma doença e para induzir uma resposta imune
CA3049991A1 (en) * 2017-01-11 2018-07-19 The Trustees Of The University Of Pennsylvania Nucleoside-modified rna for inducing an immune response against zika virus
EP3412307A1 (en) * 2017-06-07 2018-12-12 Institut Pasteur Recombinant measles virus expressing zika virus proteins and their applications

Similar Documents

Publication Publication Date Title
JP2019506175A5 (https=)
Zens et al. Memory CD4 T cells in influenza
US12239699B2 (en) Immunogen for broad-spectrum influenza vaccine and application thereof
JP2015501656A5 (https=)
JP6333730B2 (ja) 改善されたil−12遺伝子構築物を含む組成物、及びそれを用いたワクチン、免疫治療剤及び方法
JP2012515557A5 (https=)
JP2014534202A5 (https=)
FI3872085T3 (fi) Esimuotoiset virussekvenssit ja niiden käytöt
JP2014507146A5 (https=)
JP2010516290A5 (https=)
JP2018523668A5 (https=)
JP2009540801A5 (https=)
JP2015501840A5 (https=)
JP2013507907A5 (https=)
JP2013515747A5 (https=)
JP2016517414A (ja) インフルエンザ核酸分子及びそれから作製したワクチン
CN112852848B (zh) 一种含密码子优化的结核分枝杆菌融合蛋白ah疫苗
JP2006514549A5 (https=)
JP2008522621A (ja) 世界的に流行するトリインフルエンザに対して迅速に応答するためのワクチン
CN103467571A (zh) 一种畜禽免疫增强剂法氏囊多肽
KR20180064158A (ko) 구제역 바이러스의 가용성 다가 항원단백질 및 이의 용도
CN103173455B (zh) 一种具有抗新城疫病毒活性的鹅源基因rig-i及其应用
JP2013504600A5 (https=)
CN118420773A (zh) 一种重组蛋白纳米颗粒及其制备方法和在制备广谱抗流感病毒疫苗中的应用
JP2013545735A (ja) インフルエンザウィルスの組換えヘマグルチニン蛋白質及びそれを含むワクチン